Group 1F: Pan-Cancers; Clinical Trials; Symptoms & Survivorship

Wednesday, June 14
10:00 am – 11:30 am Eastern Time (US/New York)

Poster #TPS12144

A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer

Poster author Mingxiao Yang, Ph.D. is also the scientist for this session

Poster #TPS12143:

A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment

Poster author Mingxiao Yang, Ph.D. is also the scientist for this session

Mentor: Christine Hodgdon, M.S.

Christine Hodgdon was a conservation biologist before her metastatic breast cancer (MBC) diagnosis in April 2015. Her advocacy career began when she launched, an educational resource for MBC patients that includes a searchable clinical trial database. She later co-founded GRASP – Guiding Researchers & Advocates to Scientific Partnerships which empowers patients, clinicians, and researchers to exchange ideas and learn from each other.  She is the research working group co-lead of the MBC Alliance and spearheads the Breast Cancer Brain Metastasis (BCBM) Initiative: Marina Kaplan Project with the goal to address the unmet research needs of breast cancer patients living with central nervous system (CNS) metastasis. She was also a founding committee member of, a resource hub for breast cancer patients living with brain metastasis. She is the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center patient advocate representative for the Translational Breast Cancer Research Consortium (TBCRC) and she co-leads the Hopkins INSPIRE (Influencing Science through Patient-Informed Research & Education) Advocacy Program. Her advocacy work is inspired and driven by the loss of many friends to MBC.

Twitter: @christeeny513

Scientist: Mingxiao (Ming) Yang, Ph.D.

Mingxiao Yang is a senior research scientist in Integrative Medicine Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. His research is dedicated to survivorship symptom care using integrative approaches (i.e., acupuncture, massage, exercise, Tai Chi, and cognitive behavioral therapy) to ultimately improve patients’ quality of life.

For over ten years, he has developed solid expertise in comparative effectiveness and outcome research, symptom science, and integrative medicine. He has unique specialties in integrating metabolomics into the quest for metabolic signatures of integrative therapies in the general population and cancer survivors.

His training experience from East to West enables him to connect with patients, scholars, and trainees of different backgrounds. As a licensed Chinese medicine doctor in China, he has experience in real-world patient care and has managed study participants in the first herbal medicine trial at MSKCC. Under a National Cancer Institute funding mechanism, he is pushing the boundaries of precision integrative sleep care among cancer survivors. At MSKCC, he taught the course Evidence-based Medicine in Herbal Therapy in Oncology. He coordinated the Global Research in Integrative Oncology Training program, engaging scholars from Nigeria, India, China, and South Korea.